Results 121 to 130 of about 1,228,094 (210)

Hypereosinophilic syndrome with central nervous system involvement: a case report. [PDF]

Front Neuroimaging
Xu W, Zhang C, Wang F, Liu X, Zhang X, Mao F, Wang X, Zhang X.   +7 more
europepmc   +1 more source

Organ Involvement and Constitutional Symptoms in Idiopathic Hypereosinophilic Syndrome: A 72-Patient Single-Centre Cohort. [PDF]

J Clin Med
Łacwik P, Kupryś-Lipińska I, Kucharczyk A, Rosato A, Adamczewska M, Damiański P, Ochab D, Mościcka A, Lichota P, Kupczyk M, Pałczyński C, Kuna P.   +11 more
europepmc   +1 more source

Refractory Hypereosinophilic Syndrome With Clonal T-Cell Receptor Rearrangement Treated With JAK Inhibition Following Incomplete Response to IL-5 Blockade. [PDF]

Case Rep Hematol
McKaughan KW, Truong PV, Bongers G.
europepmc   +1 more source

Hypereosinophilic syndrome with Löffler endocarditis and multiple cerebral infarctions in a patient with a CLL-phenotype clonal B-cell population: a case report. [PDF]

Front Cardiovasc Med
Wang H, Zhu F, Hu H.
europepmc   +1 more source

Laboratory Aspects and Diagnostic Challenges in a Case of Hypereosinophilic Syndrome. [PDF]

Cureus
Rossi V, Velocci S, Bernardini S, Morello M.   +3 more
europepmc   +1 more source

Ischemic Stroke in Hypereosinophilic Syndrome: A Clinicopathologic Study of Two Cases. [PDF]

Neuropathology
Martin KC, Straathof D, Lai C, Vinters HV.   +3 more
europepmc   +1 more source

Panuveitis Associated With Idiopathic Hypereosinophilic Syndrome. [PDF]

J Vitreoretin Dis
Burggraaf-Sánchez de Las Matas R, Garijo-Bufort M, Juan-Ribelles B, Benavent-Corai V, Ortiz-Salvador M, Gimeno-Brosel MT.   +5 more
europepmc   +1 more source

Idiopathic Hypereosinophilic Syndrome Presenting as Isolated Right Ventricular Endomyocardial Fibrosis With Intracavitary Thrombus: A Multimodality Imaging Case Report. [PDF]

Cureus
Loudiyi N, Malki M, Erregui H, Mouine N, Benyass A.   +4 more
europepmc   +1 more source

Author Correction: Benralizumab versus placebo for hypereosinophilic syndrome: a randomized, placebo-controlled phase 3 trial. [PDF]

Nat Med
Ogbogu PU, Roufosse F, Akuthota P, Kuna P, Groh M, Reiter A, Yokota A, Siddiqui SH, Mutsaers PGNJ, Li B, Khoury P, Bahadori LM, Bednarczyk A, Bouma G, Brooks LG, Ferreira J, Grindebacke H, Ho CN, Jain P, Palmer RL, Jison ML, Klion AD, NATRON study group.   +22 more
europepmc   +1 more source

Development of a Patient-Reported Outcome Measure for Hypereosinophilic Syndrome. [PDF]

J Allergy Clin Immunol Pract
Khoury P, Mahmood S, Berry A, Mata D, Kimel M, McCormack J, Prussin C, Klion A.   +7 more
europepmc   +1 more source